Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Related articles

1. Efficacy of a New Selective Indole-based Histone Deacetylase 10 Inhibitor in Targeted Anticancer Therapy

   This article has 9 authors:

   1. Amer H. Tarawneh
   2. Salah A. Al-Trawneh
   3. Talha Z. Yesiloglu
   4. Matthes Zessin
   5. Dina Robaa
   6. Cyril Barinka
   7. Mike Schutkowski
   8. Wolfgang Sippl
   9. Samir A. Ross

2. Role of the NuRD complex and altered proteostasis in cancer cell quiescence

   This article has 14 authors:

   1. Qi Jiang
   2. Michelle Ertel
   3. Austin Arrigo
   4. Sara Sannino
   5. Jennifer L. Goeckeler-Fried
   6. April Sagan
   7. Betsy Ann Varghese
   8. Daniel D. Brown
   9. Wayne Stallaert
   10. Adrian Lee
   11. Amanda M. Clark
   12. Jeffrey L. Brodsky
   13. Hatice U. Osmanbeyoglu
   14. Ronald J. Buckanovich

3. HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway

   This article has 12 authors:

   1. Zhenyang Gu
   2. Yuchen Liu
   3. Yifan Jiao
   4. Hao Wang
   5. Lili Wang
   6. Ning Le
   7. Xiawei Zhang
   8. Qingyang Liu
   9. Yang Xu
   10. Chunji Gao
   11. Daihong Liu
   12. Liping Dou